Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 275 of 506 entries
View as:

Safety and Efficacy of a New Formulation of Bimatoprost/Timolol Ophthalmic Solution Compared With Bimatoprost/Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01177098 Org: User:
Start: 10/31/10 End: 02/29/12 Due: 02/28/13

A Study Comparing IOP-Lowering Treatments to Bimatoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01646151 Org: User:
Start: 05/31/12 End: 04/30/13 Due: 04/30/14

BOTOX® Open-Label Treatment in Pediatric Upper Limb Spasticity

Phase: N/A Priority: Normal
NCT ID: NCT01603615 Org: User:
Start: 10/30/12 End: 09/03/18 Due: 09/03/19

A Phase II Study of ACZONE™ (Dapsone) Gel, 5% As a Treatment For Tarceva® (Erlotinib)Related Rash

Phase: N/A Priority: Normal
NCT ID: NCT00343187 Org: User:
Start: 06/30/06 End: 07/31/07 Due: 07/31/08

A Long-Term Extension Study of OnabotulinumtoxinA (BOTOX®) for Urinary Incontinence Due to Neurogenic Detrusor Overactivity

Phase: N/A Priority: Normal
NCT ID: NCT01852058 Org: User:
Start: 01/11/14 End: 10/03/19 Due: 10/03/20

Physiopathologic Aspects and Quality of Life in Participants With Eye Dark Circles

Phase: N/A Priority: Normal
NCT ID: NCT03400202 Org: User:
Start: 02/02/18 End: 11/07/18 Due: 11/07/19

Safety and Efficacy of a New Treatment as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) Treatment in Patients With Age-Related Macular Degeneration (AMD)

Phase: N/A Priority: Normal
NCT ID: NCT00511706 Org: User:
Start: 11/01/07 End: 03/01/09 Due: 03/01/10

Safety and Effectiveness of Juvederm(R) Ultra XC Injectable Gel for Lip Augmentation

Phase: N/A Priority: Normal
NCT ID: NCT01197495 Org: User:
Start: 08/01/10 End: 06/15/15 Due: 06/15/16

Long-term 24-month Follow-up Study on Safety and Maintenance of Efficacy of ATX-101 (Sodium Deoxycholate Injection)

Phase: N/A Priority: Normal
NCT ID: NCT03682471 Org: User:
Start: 02/14/12 End: 12/13/13 Due: 12/13/14

A FDG-PET Study of AGN-242071 Added to Standard-of-Care (Donepezil ± Memantine) for the Treatment of Participants With Mild to Moderate Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT03316898 Org: User:
Start: 09/30/18 End: 11/04/18 Due: 11/04/19

A Study of 2 Doses of MAP0010 and Placebo in Asthmatic Children

Phase: N/A Priority: Normal
NCT ID: NCT00569192 Org: User:
Start: 12/31/07 End: 01/31/09 Due: 01/31/10

A Study to Determine the Prevalence of Inflammatory Dry Eye Disease in Patients Prior to Cataract Removal

Phase: N/A Priority: Normal
NCT ID: NCT01882413 Org: User:
Start: 06/30/13 End: 03/31/14 Due: 03/31/15

A Safety and Efficacy Study of Bimatoprost 0.01% in Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OH)

Phase: N/A Priority: Normal
NCT ID: NCT01594970 Org: User:
Start: 03/31/12 End: 01/31/13 Due: 01/31/14

Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01217606 Org: User:
Start: 01/31/11 End: 06/30/15 Due: 06/30/16

Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00332059 Org: User:
Start: 05/31/03 End: 09/30/04 Due: 09/30/05

A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration

Phase: N/A Priority: Normal
NCT ID: NCT02087085 Org: User:
Start: 05/09/14 End: 03/30/18 Due: 03/30/19

Evaluation of AGN-150998 in Exudative Age-related Macular Degeneration (AMD)

Phase: N/A Priority: Normal
NCT ID: NCT01397409 Org: User:
Start: 09/01/11 End: 04/30/14 Due: 04/30/15

Study of AGN-190584 Eye Drops to Assess Safety and Efficacy in Participants Aged 40-80 Years With Pseudophakic Presbyopia

Phase: N/A Priority: Normal
NCT ID: NCT05393089 Org: User:
Start: 06/09/22 End: 04/04/23 Due: 04/04/24

Retrospective Data Collection Study in Patients With Macular Oedema Receiving OZURDEX®

Phase: N/A Priority: Normal
NCT ID: NCT02181530 Org: User:
Start: 07/31/14 End: 10/31/14 Due: 10/31/15

Study of Bimatoprost Solution in Increasing Eyelash Prominence in African Americans With Eyelash Hypotrichosis

Phase: N/A Priority: Normal
NCT ID: NCT00958035 Org: User:
Start: 11/30/09 End: 08/31/10 Due: 08/31/11

A Study of the Safety and Efficacy of AGN-214868 in Patients With Postherpetic Neuralgia

Phase: N/A Priority: Normal
NCT ID: NCT01129531 Org: User:
Start: 06/30/10 End: 01/31/12 Due: 01/31/13

A Study to Assess Adverse Events and Change in Disease Activity of HArmonyCa Lidocaine Injectable Gel for Mid Face Soft Tissue Augmentation in Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT05452070 Org: User:
Start: 09/02/22 End: 05/08/25 Due: 05/08/26

Study of Cyclosporine in Post-LASIK Patients

Phase: N/A Priority: Normal
NCT ID: NCT00991458 Org: User:
Start: 10/31/09 End: 04/30/11 Due: 04/30/12

Voiding Efficiency, a Predictor of Clean Intermittent Catheterization (CIC)

Phase: N/A Priority: Normal
NCT ID: NCT03043287 Org: User:
Start: 05/12/17 End: 09/30/19 Due: 09/30/20

Clinical Trial to Evaluate the Symptoms in Symptomatic Contact Lens Wearers Following Application of Intranasal Tear Neurostimulator Versus Control

Phase: N/A Priority: Normal
NCT ID: NCT03325673 Org: User:
Start: 11/22/17 End: 11/29/18 Due: 11/29/19